Clinical-laboratory characteristics of ANA-positive chronic Idiopathic urticaria
Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, Spector S, Maurer M: A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
Among the associated skin disorders chronic idiopathic urticaria
, vitiligo, alopecia areata were observed with increased frequency in patients with thyroid disorders when compared to controls and had a statistically significant association (p <0.
Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria
," International Journal of Dermatology, vol.
According to the drug's developer, Genentech, omalizumab is the first biologic and the first medicine approved for chronic idiopathic urticaria
since nonsedating [H.
chronic idiopathic urticaria
(CIU; chronic hives without a known cause) who continue to have hives that are not controlled by H1-antihistamine treatment.
We are pleased with the results of the ASTERIA II study, as people with chronic idiopathic urticaria
unresponsive to H1 antihistamines need new treatment options," said Hal Barron, M.
Therefore, a part of chronic idiopathic urticaria
has shifted into this group.
Chung MC, Symons C, Gilliams J, Kaminski ER: Stress, psychiatric comorbidity and coping in patients with chronic idiopathic urticaria
NEW ORLEANS -- Colchicine is an effective steroid-sparing agent that can be used to treat refractory chronic idiopathic urticaria
, based on data from a review of adults who received colchicine for CIU from 2003 to 2008.
The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria
Low dose cyclosporine A in the treatment of severe chronic idiopathic urticaria